Publisher
Discover STM Publishing Ltd.
Reference8 articles.
1. Ahmed MA, Hassan KY. Case Report: Epidermodysplasia verruciformis. Sudanese Journal of Dermatology. 2005;3:43-7. doi:10.4314/sjd.v3i1.32852.
2. Berthelot C, Dickerson MC, Rady P, He Q, Niroomand F, Tyring SK, et al. Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod. J Am Acad Dermatol. 2007;56:882-6. doi:10.1016/j.jaad.2007.01.036.
3. de Oliveira WRP, Neto CF, Rivitti EA. The lack of a clinical effect of cimetidine in the treatment of epidermodysplasia verruciformis. J Am Acad Dermatol. 2004;50:e14; author reply e15. doi:10.1016/j.jaad.2003.12.037.
4. Hu W, Nuovo G, Willen M, Somach S. Epidermodysplasia verruciformis in two half brothers with HIV infection. J Cutan Med Surg. 2004;8:357-60. doi:10.1007/s10227-005-0022-6.
5. Lutzner MA. Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis. Bull Cancer. 1978;65:169-82.